Project description:To explore the relationship between SARS-CoV-2 infection in different time before operation and postoperative main complications (mortality, main pulmonary and cardiovascular complications) 30 days after operation; To determine the best timing of surgery after SARS-CoV-2 infection.

| 5792 | ecrin-mdr-crc

[Editorial] COVID?19: Post?lockdown guidelines.

Project description:Since March, 2020, in response to the COVID?19 pandemic, many countries have been on lockdown (at different levels of severity), restricting many activities and businesses that involve gatherings of large numbers of people in close proximity. Currently (early June, 2020), countries across the globe are in different stages of easing lockdown restrictions. Public policies for behaviors and actions during this transition period vary widely across countries and within country jurisdictions. The present editorial will address potential policies that could minimize resurgence of the present pandemic (the 'second?wave') and reduce the likelihood and severity of similar future pandemics.

| S-EPMC7307834 | biostudies-literature

Editorial commentary: a journey towards least invasive thoracic surgery?

Project description: Not available

| S-EPMC8577972 | biostudies-literature

Editorial Commentary on the paper "Mandatory vaccination in Europe".

Project description: Not available

| S-EPMC7347765 | biostudies-literature

Editorial: Developmental delay and intellectual disability.

Project description: Not available

| S-EPMC9493353 | biostudies-literature

Editorial: COVID-19 and diabetes, volume II.

Project description: Not available

| S-EPMC9885184 | biostudies-literature

Editorial: COVID-19 immunology and organ transplantation.

Project description:Purpose of reviewThe aim of this study was to provide a critical appraisal of the literature on the effects of the COVID-19 pandemic on organ transplantation, with a specific focus on lung transplantation given the predominant pulmonary involvement of the virus.Recent findingsThere was a significant decrease in lung transplant volumes during the first wave of the COVID-19 pandemic due to a combination of reduced availability of donors and an imbalance between waitlist additions and inactivations. SARS-CoV-2 infection was subsequently associated with an exuberant immune response that can lead to the development of postinfectious fibrotic lung disease. Few lung transplants have been performed in previously infected recipients and long-term outcomes remain unknown. Although the lung transplant volume rebounded during the second wave, it is unclear what the long-term effects of healthcare resource limitation and public health measures will have on transplant volumes in the future. Outcomes after SARS-CoV-2 infection in previous lung transplant recipients appear to be worse than the general public, and, although an immunosuppressed state likely contributes to these outcomes, whether immunosuppression should be altered in those exposed to or infected with SARS-CoV-2 remains unanswered in the absence of unequivocal data.SummaryThe COVID-19 pandemic has presented a number of challenges for lung transplant programs across the globe. Multiple research questions remain to be answered in order to optimally manage lung transplant recipients in the context of this pandemic.

| S-EPMC8297460 | biostudies-literature

Editorial commentary: Host and viral factors in emergent influenza virus infections.

Project description: Not available

| S-EPMC3967827 | biostudies-literature